Empresa Myovant Sciences Ltd.
Acciones
MYOV
BMG637AM1024
Biotecnología e investigación médica
Resumen de negocios
Número de empleados: 579
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
David C. Marek
CEO | Chief Executive Officer | 59 | 04/01/21 |
Adele Gulfo
BRD | Director/Board Member | 61 | 27/12/19 |
Marianne Romeo
PRN | Corporate Officer/Principal | 56 | - |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Adele Gulfo
BRD | Director/Board Member | 61 | 27/12/19 |
David C. Marek
CEO | Chief Executive Officer | 59 | 04/01/21 |
Director/Board Member | 59 | 22/10/22 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 97 235 316 | 46 097 791 ( 47,41 %) | 0 | 47,41 % |
Información de la empresa
Myovant Sciences Ltd.
11-12 St. James?s Square Suite 1, 3rd Floor
SW1Y 4LB, London
+
http://www.myovant.comSector
Varia. 1 de ene. | Capi. | |
---|---|---|
-0,81 % | 41,36 mil M | |
+44,25 % | 41,3 mil M | |
+2,61 % | 39,61 mil M | |
-15,14 % | 25,62 mil M | |
+5,29 % | 24,09 mil M | |
-23,88 % | 18,38 mil M | |
+25,22 % | 11,85 mil M | |
-2,08 % | 11,82 mil M | |
+8,77 % | 11,07 mil M |